Evidence map›Paper›PMID 31777839›Full record

ArticleACR open rheumatology2019

Supplementing Claims Data with Electronic Medical Records to Improve Estimation and Classification of Rheumatoid Arthritis Disease Activity: A Machine Learning Approach.

Candace H Feldman, Kazuki Yoshida, Chang Xu, Michelle L Frits, Nancy A Shadick, Michael E Weinblatt, Sean E Connolly, Evo Alemao, Daniel H Solomon

Open access · goldAbstract read
In one paragraph

Article in ACR open rheumatology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Machine Learning in Rheumatic Diseases.Clinical reviews in allergy & immunology · 2021
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Candace H FeldmanBrigham and Women's Hospital Boston Massachusetts.ORCID https://orcid.org/0000-0002-4980-9770
Kazuki YoshidaBrigham and Women's Hospital Boston Massachusetts.ORCID https://orcid.org/0000-0002-2030-3549
Chang XuBrigham and Women's Hospital Boston Massachusetts.
Michelle L FritsBrigham and Women's Hospital Boston Massachusetts.
Nancy A ShadickBrigham and Women's Hospital Boston Massachusetts.ORCID https://orcid.org/0000-0003-3953-845X
Michael E WeinblattBrigham and Women's Hospital Boston Massachusetts.
Sean E ConnollyBristol-Myers Squibb Princeton New Jersey.
Evo AlemaoBristol-Myers Squibb Princeton New Jersey.ORCID https://orcid.org/0000-0001-9292-9420
Daniel H SolomonBrigham and Women's Hospital Boston Massachusetts.ORCID https://orcid.org/0000-0001-8202-5428
Brigham and Women's Hospital · USBristol-Myers Squibb (United States) · US

Funding

Patient Centered Outcomes Research in RheumatologyK24AR055989 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI SOLOMON, DANIEL HAL · 2008 to 2017
$1.5M
Avoidable Acute Care Use among Patients with LupusK23AR071500 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI FELDMAN, CANDACE HILLARY · 2017 to 2021
$945k
NIAMS NIH HHS K23 AR071500NIAMS NIH HHS K24 AR055989
6 · The paper itself

Abstract

objectivePrevious attempts to estimate rheumatoid arthritis (RA) disease activity using claims data only did not yield high performance. We aimed to assess whether supplementing claims data with readily available electronic medical record (EMR) data might result in improvement.

methodsWe used a subset of the Brigham and Women's Hospital Rheumatoid Arthritis Sequential Study (BRASS) that had linked Medicare claims. The disease activity score in 28 joints with C-reactive protein (DAS28-CRP) was considered the gold standard of measure. Variables in the linked Medicare claims, as well as EMR recorded in the preceding one-year period were used as potential explanatory variables. We constructed three models: "Claims-Only," "Claims + Medications," and "Claims + Medications + Labs (laboratory data from EMR). We selected variables via adaptive LASSO. Model performance was measured with adjusted R2 for continuous DAS28-CRP and C-statistics for binary category classification (high/moderate vs low disease activity/remission).

resultsWe identified 300 patients with laboratory data and linked Medicare claims. The mean age was 68 years and 80% were female. The mean (SD) DAS28-CRP was 3.6 (1.6) and 51% had high or moderate DAS28-CRP. For the continuous estimation, the adjusted R2 was 0.02 for Claims-Only, 0.09 for Claims + Medications, and 0.18 for Claims + Medications + Labs. The C-statistics for discriminating the binary categories were 0.61 for Claims-Only, 0.68 for Claims + Medications, and 0.76 for Claims + Medications + Labs.

conclusionAdding EMR-derived variables to claims-derived variables resulted in modest improvement. Even with EMR variables, we were unable to estimate continuous DAS28-CRP satisfactorily. However, in claims-EMR models, we were able to discriminate between binary categories of disease activity with reasonable accuracy.

Identifiers

PMID31777839
PMCPMC6857973
OpenAlexW2971798232

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.